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living cells by brightness analysis. However, the study of cytoplasmic proteins that interact with the plasma membrane is
challenging with FFS. If the cytoplasmic section is thinner than the axial size of the observation volume, cytoplasmic and
membrane-bound proteins are coexcited, which leads to brightness artifacts. This brightness bias, if not recognized, leads to
erroneous interpretation of the data. We have overcome this challenge by introducing dual-color z-scan FFS and the addition
of a distinctly colored reference protein. Here, we apply this technique to study the cytoplasmic interactions of the Gag proteins
from human immunodeficiency virus type 1 (HIV-1) and human T-lymphotropic virus type 1 (HTLV-1). The Gag protein plays
a crucial role in the assembly of retroviruses and is found in both membrane and cytoplasm. Dual-color z-scans demonstrate
that brightness artifacts are caused by a dim nonpunctate membrane-bound fraction of Gag.We perform an unbiased brightness
characterization of cytoplasmic Gag by avoiding the membrane-bound fraction and reveal previously unknown differences in the
behavior of the two retroviral Gag species. HIV-1 Gag exhibits concentration-dependent oligomerization in the cytoplasm,
whereas HTLV-1 Gag lacks significant cytoplasmic Gag-Gag interactions.INTRODUCTIONTwo-photon fluorescence fluctuation spectroscopy (FFS)
monitors the fluorescence fluctuations caused by single
molecules that migrate in and out of a diffraction-limited
observation volume. Analysis of the fluctuations provides
information on the concentration, mobility, and brightness
of fluorescent proteins (1–3). An exciting application of
FFS lies in the characterization of protein-protein interac-
tions in living cells by brightness analysis (1,4). However,
caution is required because the cellular environment is far
more complex than that in an aqueous solution. We
recently demonstrated that cytoplasmic brightness analysis
leads to artifacts if the observation volume exceeds the
physical boundaries of the cell (5). Z-scan FCS was intro-
duced to account for artifacts in the study of diffusion in
both model and cellular lipid bilayers (6–8). Our group
adapted this technique to account for the brightness arti-
facts observed in thin cells (5). Here we expand the reper-
toire of FFS by characterizing retroviral Gag proteins
(9,10), which are found both in the cytoplasm and on the
plasma membrane. Gag molecules are retroviral structural
proteins that have been shown to be sufficient for the
production and release of viral-like particles (VLPs).
VLPs exhibit similar size and morphology to immature
infectious virions (11,12). Hundreds to thousands of Gag
proteins assemble and organize at the plasma membraneSubmitted December 28, 2010, and accepted for publication February 7,
2011.
*Correspondence: mueller@physics.umn.edu or mansky@umn.edu
Editor: Michael Edidin.
 2011 by the Biophysical Society
0006-3495/11/03/1587/9 $2.00to form individual VLPs (13–15). It is believed, however,
that the process of viral assembly is initiated in the cyto-
plasm, followed by Gag targeting to the membrane for
further assembly (16–18). In this study, we investigated
the cytoplasmic Gag-Gag interactions of two viruses
(HIV-1 and HTLV-1) to characterize the initial steps of
the virus particle assembly pathway.
Cells expressing Gag display bright puncta at the
membrane, which are the putative assembly sites of VLPs.
Although it is easy to avoid puncta, FFS measurements
resulted in artifacts that were ultimately traced to the exis-
tence of a nonpunctate Gag-population at the membrane.
The finite thickness of cytoplasmic sections leads to coexci-
tation of cytoplasmic and membrane-bound Gag, which
obfuscates brightness analysis. In this work, we introduced
a modified z-scan FFS technique to identify appropriate
measurement positions for brightness analysis of cyto-
plasmic Gag proteins. The modified FFS technique relies
on a dual-color z-scan, which was recently introduced into
FCS (6).
We applied the technique to quantify cytoplasmic Gag-
Gag interactions using brightness analysis for the first
time (to our knowledge). Our results demonstrate inter-
esting differences in the behavior of HTLV-1 and HIV-1
Gag, which appear related to the myristic acid moiety
known to be involved in Gag membrane targeting
(16–18). We anticipate that the methodology described
in this article will prove useful in the characterization
of other cytoplasmic proteins that interact with the
membrane.doi: 10.1016/j.bpj.2011.02.008
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FFS instrumentation
A mode-locked Ti:Sapphire laser (Tsunami, Spectra-Physics, Mountain
View, CA) serves as a source for two-photon excitation of a modified
Axiovert 200 microscope (Zeiss, Thornwood, NY) as previously described
(1). Cells reside in a chamber slide mounted on a motorized stage (PZ2000
piezo stage; ASI, Eugene, OR). The location and positioning of cells ex-
pressing both the Gag-EYFP construct and mCherry was achieved using
fluorescence epi-illumination. The microscope was subsequently switched
to bright-field illumination to verify cell-health as well as to locate a
measurement position which appeared free from organelles. Finally, fluo-
rescence epi-illumination was used to ensure that no puncta were present
at the chosen measurement location.
Once a cell was selected, the excitation source was switched to the
Ti:Sapphire laser for FFS experiments. Excitation light is focused through
a 63 Plan Apochromat (Zeiss) oil immersion objective (N.A. ¼ 1.4).
Control experiments (data not shown) confirm that 0.3 mWexcitation power
is sufficiently low to avoid saturation and photobleaching effects. Each FFS
measurement lasts 82 s and uses two-photon excitation of the sample at
1000 nm. Intensity z-scans were obtained using a PZ2000 piezo stage
(ASI, Eugene, OR) to move the sample in the axial direction. Scan voltages
were controlled by a model No. 33250A arbitrary waveform generator (Agi-
lent Technologies, Santa Clara, CA) running a linear ramp signal with a
frequency of 30.5 mHz and a peak-to-peak amplitude of 1.4 V. This voltage
corresponds to an axial travel of 14.2 mm. The fluorescence emission of the
FFS and z-scan measurements was separated into two different detection
channels with a 580-nm dichroic mirror (585DCXR; Chroma Technology,
Bellows Falls, VT). Photon counts were detected with avalanche photodi-
odes (SPCM-AQ-14; Perkin-Elmer, Boston, MA) and recorded by a data
acquisition card (ISS, Champaign, IL), which stores the complete sequence
of photon counts using sampling frequencies ranging from 20 to 200 kHz.
Two-photon imaging is described in the Supporting Material.Sample preparation and data analysis
Plasmid construction, transfection, and cell treatment are described in the
Supporting Material. The photon counts were analyzed with programs
written in IDL 6.0 (Research Systems, Boulder, CO). The determination
of protein concentrations and brightness values from FFS experiments
has been described previously (1,2,4). The z-scan fluorescent intensity
traces F(z;h) were fit using (5)
Fðz; hÞ ¼ A
Z
RIPSFðzÞ , Sðzþ zÞdz: (1)
The fluorescent intensity at position z for a slab of height h depends on the
amplitude A and the spatial convolution of the radially integrated point
spread function (PSF) with a sample shape factor S. For cell measurements
the shape factor is modeled as a slab of height h,
Sðz; h0; hÞ ¼

1; h0<z<h0 þ h
0; otherwise
: (2)
The parameter h0 is required to describe the difference between the initial
position of the z-scan and the start position of the slab. The radially integrated
PSF of the observation volume is modeled using a modified Gaussian-
Lorentzian PSF as previously described (5). The beam parameters of the
PSF were determined daily from fits of z-scan profiles to Eq. 1 and changed
very little. The axial beam waist ZR is ~0.7 mm and the y factor is ~1.9.FIGURE 1 Normalized brightness of HTLV-1 Gag-EYFP expressed in
HeLa cells measured at locations that appeared free of puncta. The data
were screened to eliminate artifacts due to intensity spikes. Normalized
brightness values of <1 indicate an unphysical stoichiometry of <1 for
Gag-EYFP.RESULTS
Cells which express either the HIV-1 Gag-EYFP or the
HTLV-1 Gag-EYFP construct exhibit both bright punctaBiophysical Journal 100(6) 1587–1595and a diffuse, dim fluorescence from cytoplasmic regions
of the cell (see Fig. S1 of the Supporting Material). The
puncta are generally believed to be plasma membrane-
anchored sites of VLP assembly containing hundreds to
thousands of individual Gag copies (19–21), whereas the
diffuse staining is believed to be the cytoplasmic fraction
of Gag. To investigate the poorly understood cytoplasmic
oligomerization-state of HTLV-1 and HIV-1 Gag, FFS
brightness measurements of cytoplasmic Gag need to be
conducted. To avoid contamination of the cytoplasmic
Gag fluorescence by the puncta, FFS measurements are
conducted at cellular locations that are free of puncta. The
normalized brightness values acquired by this method are
shown in Fig. 1 as a function of concentration for HTLV-1
Gag-EYFP measured in HeLa cells. Each point in the graph
represents a separate cytoplasmic measurement. Normal-
ized brightness b is determined by calculating the ratio of
the brightness of Gag-EYFP (lapp) to the brightness of an
EYFP monomer (lmonomer) (1). Normalized brightness
provides a measure of the average stoichiometry of the
labeled proteins. For example, a normalized brightness of
b ¼ 2 corresponds to a dimer. The data has been screened
for fluorescence intensity spikes that were found infre-
quently as described in the Supporting Material.
Despite avoiding puncta and the removal of intensity
spikes, the brightness values in Fig. 1 exhibit an unusual
feature. Whereas the majority of the data fall between
monomeric and dimeric brightness values, a substantial frac-
tion of the data shows a normalized brightness significantly
below a value of 1. Such low brightness values correspond
to an unphysical Gag-EYFP stoichiometry of less than
monomer. Despite the unphysical results, fluorescence auto-
correlation data exhibited no unusual features. A discussion
of the autocorrelation data is provided in the Supporting
Material. This unexpected result warrants a careful examina-
tion of potential artifacts that arise in FFS experiments.
One source of experimental artifacts in cytoplasmic
brightness measurements is the cell thickness (5). FFS
Cytoplasmic Brightness by Z-Scan FFS 1589defines brightness as the average fluorescence intensity of a
single molecule sampled at all locations of the observation
volume. Focusing on the midsection of a thin sample
excludes access of the fluorophore to the outer edges of
the observation volume, where the intensity is lowest.
As a consequence, cytoplasmic Gag-EYFP spends most of
the time in the higher intensity, central areas of the excita-
tion light, and the resulting spatial average skews the
apparent brightness upwards. Z-scan FFS was introduced
to correct this geometry-related artifact (5). In this tech-
nique, the observation volume is scanned uniformly along
the z axis at a given cell location.
The FFS measurement is performed at the same location
with the focus at the midsection of the cell. The intensity
trace of the z-scan is determined by the convolution of the
observation volume with the geometric profile of the cell
at the location of the measurement. Based on previous
work we modeled the observation volume of two-photon
excitation by a modified Gaussian-Lorentzian PSF and the
cell profile as a slab of thickness L with uniform fluorophore
distribution (5). The fit of the intensity trace to Eq. 1 deter-
mines the shape factor g2, which incorporates the geometry
effect of sample thickness (5,22). This shape factor is used
to calculate the corrected brightness of the FFS measure-
ment. Our earlier study found that without this correction
the bias in brightness could be as high as a factor of 2, but
would always lead to an increase in brightness. Thus,
z-scan FFS has the potential to reduce some of the high
brightness scatter in the Gag-EYFP data, but cannot explain
abnormally low brightness values.
Another factor potentially influencing FFS experiments
is the presence of Gag-EYFP at the plasma membrane.
Although we selected measurement sites that appear free
of puncta, we cannot rule out the presence of membrane-
bound Gag-EYFP with certainty. The fluorescence contribu-
tions from a population of Gag-EYFP at the membrane
could influence brightness determination and complicate
positioning of the observation volume. Brightness measure-
ments are typically conducted at the center of the cellular
slab, which is identified by focusing the observation volume
at the point of maximum fluorescent intensity along the
z-profile of the cell. If plasma membrane-bound fluorescent
protein is present, the maximum of the fluorescent intensity
can shift toward the periphery of the cell, which leads to an
off-center position of the observation volume. These issues
confound the interpretation of brightness measurements.
However, it is difficult to identify experimentally the exis-
tence of a membrane fraction if its fluorescence intensity
is of the same order as the cytoplasmic intensity. We found
that autocorrelation analysis of the FFS data is not sufficient
to identify unequivocally the presence of membrane-bound
protein as discussed in the Supporting Material.
These challenges prompted us to introduce an internal
standard by coexpressing the red fluorescent protein
mCherry together with Gag-EYFP. Because mCherry isa soluble protein that does not interact with membrane, it
is a suitable protein for finding the center of the cell slab,
determining cell thickness, and identifying Gag-EYFP at
the membrane. The green channel records the fluorescence
from Gag-EYFP, whereas the red channel records mCherry
fluorescence as long as the crosstalk from Gag-EYFP is
removed as described in the Supporting Material. For
simplicity, we refer to the red channel when specifying
mCherry fluorescence without explicitly stating the correc-
tion procedure.
Fig. 2 shows two-color z-scan intensity traces of HeLa
cells expressing HTLV-1 Gag-EYFP and mCherry. It should
be noted that HIV-1 Gag-EYFP-expressing cells yielded
data with the same features as presented in Fig. 2. All inten-
sity curves have been normalized to a maximum intensity of
1 to facilitate comparison. The z-scan profiles of Fig. 2 A
illustrate perfect overlap between red- and green-channel
data. Separate fits of the red- and the green-channel intensity
profile to the slab model (Eq. 1) determined a thickness of
1.86 5 0.02 mm for both channels with reduced c-square
values of 1.4 and 1.5. Both the Gag-EYFP and mCherry
fluorescence intensity profiles coincide and are well
described by a simple slab model as expected for purely
cytoplasmic protein. We refer to z-scans with these attri-
butes as membrane-negative, because of the absence of
membrane-associated Gag-EYFP. Next, the observation
volume is focused at the center of the slab using the red
channel and the brightness of Gag-EYFP is determined.
The cell thicknesses obtained from the z-scan data is used
to account for the impact of sample thickness on the bright-
ness. Fig. 3 A is a cartoon illustrating the hypothesized
cellular conditions which gives rise to the z-scan data seen
in Fig. 2 A. The observation volume (gradient filled oval)
is positioned in the center of the cytoplasm, with cyto-
plasmic Gag-EYFP being the sole Gag species present at
the measurement position.
Fig. 2 B shows z-scan data from a different cell location
than Fig. 2 A, but with comparable thickness. We notice
immediately that the intensity profiles of the green and red
channel are distinctly different. The intensity trace of the
red channel (diamonds) is symmetric, has a single peak,
and is well approximated by a fit to a simple slab model
(dashed line) with a thickness of 1.96 5 0.01 mm. Thus,
the z-scan data of the red channel demonstrate that mCherry
is cytoplasmic. In contrast, the intensity profile of the green
channel (solid line) has two peaks, is wider than the profile
of mCherry, and cannot be reproduced by a simple slab
model. The green channel data exhibits features that are
consistent with a significant population of membrane-bound
Gag-EYFP at both the top and bottom membranes, giving
rise to the two peaks as illustrated in Fig. 3 B.
The valley between the two peaks is formed by the signal
from cytoplasmic Gag-EYFP with additional contributions
from membrane-associated Gag-EYFP, which is excited at
the periphery of the observation volume. We refer to z-scansBiophysical Journal 100(6) 1587–1595
FIGURE 2 Dual-color z-scan intensity traces
from HeLa cells expressing HTLV-1 Gag-EYFP
and mCherry. Fluorescence intensity traces were
obtained for Gag-EYFP (green channel) and
mCherry (red channel) as detailed in the article.
The intensity trace with amplitude normalized to
1 is graphed versus the axial beam position. (A)
Example of a membrane-negative z-scan. The
normalized intensity trace of the green (asterisks)
and red (diamonds) channels overlaps completely.
The fit (dashed line) of the trace to a slab model
identifies a thickness of 1.86 5 0.02 mm. Purely
cytoplasmic Gag-EYFP yields a membrane-nega-
tive z-scan. (B) Example of a membrane-positive
z-scan. The distinct shape of the green-channel
curve (solid line) indicates the presence of
membrane-bound Gag-EYFP. For comparison,
cytosolic mCherry is represented by the red-
channel data (diamonds) and its fit (dashed line)
to a slab model. (C) Example of a membrane-posi-
tive z-scan. Here the shape of the green-channel
data (solid line) is not sufficient to recognize the
presence of membrane-bound Gag-EYFP. Com-
parison with the red-channel curve (diamonds) is
needed to identify the existence of membrane-bound Gag. (Dashed line) Fit of the red-channel data to a slab model. (D) Example of a z-scan at a puncta
location. Normalization of the amplitude of the green-channel curve (solid line) was performed outside the region with the intensity spike to illustrate the high
intensity of the punctum. The mCherry fluorescence (diamonds) of the red channel and its fit (dashed line) to a slab model is shown for reference. Comparison
of the green and red channels reveals in addition a dim nonpunctate Gag-EYFP membrane fraction at the bottom membrane.
1590 Fogarty et al.that share the characteristics seen in Fig. 3 B as membrane
positive, because the data reveal the presence of
membrane-bound Gag-EYFP. Although Fig. 3 B illustrates
an example with Gag-EYFP at both the top and bottom
membranes, we also found membrane-positive z-scans
with Gag-EYFP only visible at one of the two membranes.
It is important to note that the measurement site was
selected in a region that appeared devoid of puncta. Thus,
the membrane-bound Gag-EYFP (shown as shaded boxes
in Fig. 3 B) has to represent a population of Gag that is
distinct from the puncta. Its intensity has to be much lower
than that of puncta, which indicates a low degree of oligo-FIGURE 3 Depiction of the vertical cross section of a cell with the FFS
observation volume (oval) placed at four different cytoplasm locations.
The image includes cytoplasmic Gag (dotted fill pattern), nonpunctate
membrane-bound Gag (shaded bar), and punctate Gag (solid circle). The
four measurement locations (A–D) provide an interpretation of the z-scans
of Fig. 2. (A) Location with purely cytoplasmic Gag. (B) Thick cytoplasmic
slab with nonpunctate Gag at the top and bottommembranes. (C) Thin cyto-
plasmic slab with nonpunctate Gag at the top and bottom membranes. (D)
Cytoplasmic slab with punctum at the top membrane and nonpunctate Gag
at the bottom membrane.
Biophysical Journal 100(6) 1587–1595merization and a concentration comparable to cytoplasmic
Gag. The population of membrane-bound Gag is further
believed to be nonpunctate as discussed at a later point.
Immediately before taking the z-scan, an FFS measurement
was performed at the center of the slab, which was identified
using the red-channel intensity. The normalized brightness
of the measurement was, b¼ 0.5, which is <<1. This result
strongly suggests that the unphysical low brightness values
observed in Fig. 1 are associated with the presence of
membrane-bound Gag-EYFP.
Fig. 3 C is an example in which the Gag-EYFP’s inten-
sity profile of the green channel suggests the absence of
membrane-bound Gag. However, comparison of the inten-
sity profile of the green and red channel reveals a lack of
overlap between them. The profile of the green channel
(solid line) is broadened, which indicates the presence
of a Gag membrane fraction. The mCherry fluorescence
profile of the red channel (diamonds) is reproduced by
a fit (dashed line) to a slab model with a cell thickness of
1.115 0.03 mm. However, the profile of the green channel
can also be approximated by a fit to a slab model, which
results in a thickness of 1.75 5 0.02 mm and a reduced
c-square of 1.9. Thus, the data of the green channel on its
own might lead to the false conclusion that the Gag protein
is purely cytoplasmic. The z-scan traces of Fig. 2 C are an
example in which the dual-color comparison of red and
green channels is essential for the positive identification
of Gag-EYFP at the membrane. The cartoon of Fig. 3 C
illustrates conditions that can give rise to the z-scan data
of Fig. 2 C. Just as in the case of Fig. 3 B, both cytoplasmic
Cytoplasmic Brightness by Z-Scan FFS 1591and membrane-associated Gag are present at the measure-
ment site.
The crucial difference, which gives rise to the difference
in the appearance of the two z-scans, is the cell thickness at
the point of measurement. The spatial resolution of the
observation volume is insufficient to identify the Gag fluo-
rescence from the bottom and top membranes as indepen-
dent peaks. The thin sample geometry effectively merges
the membrane and cytoplasmic fluorescence contributions
into a single, albeit slightly broadened peak. This result
implies that the relative broadening of the z-scan profile
of the green channel to that of the red channel diminishes
as the sample thickness decreases. For this reason, measure-
ment locations with a thickness of ~0.5 mm or less were
rejected, because the spatial resolution is insufficient to
unequivocally identify membrane-positive data. An FFS
measurement was performed at the center of the cellular
slab to determine the thickness-corrected brightness of
Gag-EYFP. Although the normalized brightness at this
measurement position was higher, b ¼ 0.71, than that
measured at the position of Fig. 2 B, it is still sufficiently
low to be unphysical.
Thus far, all measurements have been performed at loca-
tions free of puncta. We now purposefully target puncta to
capture their fluorescence in a z-scan experiment. Fig. 2 D
displays a successful z-scan measurement of a punctum. It
should be noted that for purposes of clarity the green
channel (solid line) was normalized using data outside of
the large intensity spike present in the data. The normaliza-
tion was performed in this manner to emphasize the spike’s
relative scale versus the red-channel control (diamonds).
The data clearly displays the profound impact of a Gag
punctum positioned at the measurement site on the fluores-
cence intensity profile of the green channel. A cartoon of
cellular conditions that give rise to the z-scan data seen in
Fig. 2 D is illustrated in Fig. 3 D. The highly oligomerized
Gag punctum resides at the top cellular membrane (solid
circle). Though it is difficult to see due to the scale
differences, the fluorescent intensity profile at the bottom
membrane of the cell also exhibits a membrane-positive
signature, which must be due to nonpunctate membrane-
bound Gag (shaded box). This difference in intensity scale
clearly establishes that there are two distinct pools of Gag
at the membrane—bright puncta and dim nonpunctate Gag.
All brightness experiments described in this article have
been performed on HeLa cells using z-scan FFS. In selected
cases, multiple FFS measurements have been conducted
in the same cell at different locations. We found both
membrane-positive and membrane-negative z-scans within
the same cell. In addition, the experiments revealed that
FFS measurements at membrane positive locations resulted
in some, but not all cases, in an unphysical low brightness.
These observations clearly spell out the need to discard all
membrane-positive FFS experiments to ensure that the
measured brightness faithfully represents cytoplasmic Gag.Selection of membrane-negative FFS experiments is in prin-
ciple straightforward by examining the z-scan profiles.
However, the z-scan and FFS measurement are not con-
ducted simultaneously, but sequentially. If measurement
locations switch from membrane-positive to -negative, or
vice versa, during the timescale of the measurements,
false-negatives and -positives are introduced, undermining
the accuracy of the selection process. We performed a series
of continuous z-scans and analyze the resulting kymographs
to determine the temporal stability of membrane-positive
and membrane-negative locations (see the Supporting
Material). These experiments establish that the sequential
z-scan and FFS experiments provide a robust method for
identifying the presence or absence of Gag-EYFP at the
membrane.
We now have the tools to revisit the brightness character-
ization of cytoplasmic Gag-EYFP. Dual-color z-scan FFS
is used to select membrane-negative experiments and deter-
mine their brightness, while discarding any measurements
with membrane-positive characteristics. Fig. 4 A shows
the normalized brightness versus concentration for cyto-
plasmic HIV-1 Gag-EYFP (diamonds) measured at
membrane-negative locations. It is immediately apparent
that dual-color z-scan FFS has been successful in removing
the unphysical low brightness values seen in Fig. 1. The
lowest normalized brightness data are consistent with mono-
meric Gag-EYFP. Brightness values slightly below 1 reflect
the statistical uncertainty in the experiment, which in our
experience is ~10% for cellular brightness measurements
(see the Supporting Material for further details concerning
brightness statistics).
The data reveal the existence of monomeric HIV-1 Gag at
low concentrations and hint at a concentration-dependent
Gag oligomerization in the cytoplasm, because the data
trends toward slightly elevated brightness values at the
upper end of the measured concentrations. This result is
consistent with the myristoyl switch model (16,17,23,24).
This model predicts that Gag-Gag interactions in the cyto-
plasm directly lead to membrane-binding through the
exposure of a myristic acid moiety at the N-terminus of
the Gag molecules. Gag monomers, on the other hand,
sequester the myristic acid moiety in a hydrophobic pocket
of the matrix domain, and thus are restricted to the
cytoplasm.
To facilitate observation of cytoplasmic Gag-Gag interac-
tions, we measured the G2A Gag mutant, which lacks
the myristoyl moiety and is therefore membrane-binding
deficient (25,26). In contrast to wild-type HIV-1 Gag, the
HIV-1 G2A mutant exhibits an increased brightness and
concentration range (Fig. 4 B). Brightness of the G2A
mutant (asterisks) increases monotonically with concentra-
tions and reaches a value of ~8, which reflects an average
complex size of eight Gag molecules. Thus, dimerization
of Gag is followed by further increase in oligomerization.
In addition, G2A Gag mutants reach cytoplasmicBiophysical Journal 100(6) 1587–1595
FIGURE 4 Normalized brightness of cyto-
plasmic Gag-EYFP versus concentration from
membrane-negative dual-color z-scan FFS data
taken in HeLa cells. (A) Normalized brightness
of HIV-1 Gag-EYFP. (B) Normalized brightness
of HIV-1 G2A Gag-EYFP (asterisks) and HIV-1
Gag-EYFP (shaded diamonds). (C) Normalized
brightness of HTLV-1 Gag-EYFP. (D) Normalized
brightness of HTLV-1 G2A Gag-EYFP (asterisks)
and HTLV-1 Gag-EYFP (shaded diamonds). The
data reveal distinct differences for the Gag-Gag
interactions for both viruses as further discussed
in the main article.
1592 Fogarty et al.concentrations almost a degree-of-magnitude-higher than
wild-type HIV-1 Gag. Despite the contrast in the two results,
the brightness of wild-type HIV-1 Gag (shaded diamonds)
and G2A mutant (asterisks) are identical over the concentra-
tion range accessible to the wild-type protein.
Fig. 4 C shows the normalized brightness versus concen-
tration for cytoplasmic HTLV-1 Gag-EYFP (diamonds)
measured at membrane-negative locations. As with the
HIV-1 Gag data, dual-color z-scan FFS has been successful
in removing the unphysical low brightness values seen in
Fig. 1. The lowest and highest normalized brightness values
are 1 and 1.6 if the experimental uncertainty in brightness
determination is taken into account. Unlike HIV-1 Gag,
there is no discernible concentration-dependence of the
brightness. We notice instead a large but uniform scatter
in the brightness throughout the concentration range. This
result points to a potential difference between HIV-1 and
HTLV-1 Gag behavior.
Analogous to our approach to HIV-1 Gag, we now turn to
the HTLV-1 Gag G2A mutant for further investigation of
cytoplasmic Gag-Gag interactions (Fig. 4 D). Again, the
G2A mutant lacks the myristoyl posttranslational modifica-
tion, and so is deficient in membrane targeting. Although the
G2AGag mutant (asterisks) reaches cytoplasmic concentra-
tions almost a degree-of-magnitude-higher than wild-type
HTLV-1 Gag, its brightness behavior departs markedly
from that of the HIV-1 G2A species. The normalized bright-
ness remains close to 1 over the entire concentration range.
The highest brightness values for the HTLV-1 G2A mutant,
at ~1.4, actually lie below the highest measured values for
wild-type HTLV-1 Gag. Another striking difference
between HTLV-1 mutant and wild-type is the degree ofBiophysical Journal 100(6) 1587–1595scatter in the G2A data (Fig. 4 D), which is considerably
higher for the wild-type protein (shaded diamonds). The
FFS characterization of HTLV-1 G2A Gag did not follow
the results expected by the myristoyl-switch model. Our
data point to the near-absence of HTLV-1 Gag oligomeriza-
tion at all cytoplasmic concentrations.DISCUSSION
Retroviral Gag proteins are the structural proteins of retro-
viruses, assembling into the retroviral structural lattice
consisting of hundreds to thousands of Gag molecules
(13,14,27). It is believed that after Gag molecules initiate
lattice assembly in the cytoplasm, the Gag-Gag interactions
target small Gag complexes to the inner leaflet of the plasma
membrane for further assembly (for reviews, see Swanstrom
and Wills (9) and Klein et al. (10)). The degree of Gag olig-
omerization in the cytoplasm remains poorly understood.
Techniques such as fluorescence resonance energy transfer
have confirmed the presence of cytoplasmic Gag-Gag inter-
actions, but quantification remains lacking (28,29). FFS
brightness analysis (1,2,4) has the potential to shed light
on this area of Gag behavior, but requires the development
and adoption of new FFS protocols.
Previous brightness studies conducted by our group were
restricted to soluble proteins residing exclusively in the
nucleoplasm or cytoplasm of cells (1,2,4). The study of
Gag characterizes a protein with simultaneous presence in
the cytoplasm and as puncta at the plasma membrane.
Although puncta were avoided in FFS measurements, the
brightness of Gag-EYFP revealed unusual characteristics,
which we ultimately linked to the presence of nonpunctate
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bound Gag-EYFP (Fig. 3 B) introduces a second species
that is coexcited with cytoplasmic Gag. The exact brightness
of a mixture of species depends on many details, but its
value will always lie between the brightness of the dimmest
and brightest species.
The membrane-bound species depicted in Fig. 3 B will
contribute an unusually low brightness, because of its
location at the periphery of the observation volume, where
the excitation intensity is weak. This reasoning implies
that membrane-bound Gag will have a lower brightness
than cytoplasmic Gag. Consequently, the brightness of the
mixture containing dim membrane-bound Gag is less than
the brightness of cytoplasmic Gag. For example, if cyto-
plasmic Gag has a normalized brightness of 1, the mixture
exhibits a value of <1. This scenario provides a qualitative
explanation for the unphysical low brightness values
observed in Fig. 1. We previously demonstrated that the
presence of immobile fluorophores decreases brightness
(30).
Note that the reduction of brightness for the current case
is not caused by immobile fluorophores, but is due to a
geometric effect that restricts mobile fluorophores to the
periphery of the observation volume. Thus, the influence
of membrane-bound Gag on FFS experiments depends in
general on geometric factors. As the cell thickness reduces,
the membrane-bound species moves closer to the center of
the observation volume (Fig. 3 C), thereby increasing its
brightness. Under these circumstances, the brightness at
the membrane is not necessarily lower than for cytoplasmic
Gag.
In fact, the small drop in brightness from the off-center
positioning of the membrane can be sufficiently small that
membrane-bound Gag is brighter than cytoplasmic Gag, if
the degree of oligomerization at the membrane is higher
than in the cytoplasm. For example, if Gag at the membrane
is predominantly dimeric, its brightness should be higher or
at least comparable to the brightness of cytoplasmic Gag. In
conclusion, adding membrane-bound Gag to a population of
cytoplasmic Gag may lead to either an increase or a decrease
in the measured brightness. Correcting the change in bright-
ness is difficult, because the sample geometry, the oligo-
meric state, and the concentration of all species play a
role. Because these parameters are not sufficiently well
known, it is best to avoid the complications that arise
from membrane-bound Gag.
Measuring in thick sections, where the observation
volume is completely contained in the cytoplasm, offers a
straightforward solution that prevents excitation of proteins
at the membrane. Because the height of spreading HeLa
cells decreases rapidly outside the nuclear region of the
cell, the only location thick enough to accommodate the
observation volume is the perinuclear region. Unfortunately,
performing quantitative FFS measurements in this region is
exceedingly difficult, because organelles and fluorescencefrom internal membranes introduce analytically intractable
artifacts. For this reason, we are forced to measure thin
cell regions. This approach requires a technique that accu-
rately identifies fluorescence contributions from the plasma
membrane to prevent brightness artifacts.
We demonstrate in this article that z-scan FFS provides
a suitable solution.
Because the z-profile of a protein with a cytoplasmic and
membrane-bound population is complex, we implemented
dual-color z-scan FFS to facilitate its characterization. The
green channel detects the EYFP-labeled protein, whereas
the red channel monitors mCherry, which serves as a marker
of the cytoplasmic volume. A membrane-negative scan is
defined by identical shapes for the green and red channels,
which signals the absence of membrane-bound protein
(Fig. 2 A). A membrane-positive scan is characterized by
deviating shapes in both channels, which identify the pres-
ence of membrane-bound protein (Fig. 2 B). The z-profile
of the green channel is often sufficient to identify
membrane-positive scans (Fig. 3 B), but comparison with
the red channel becomes crucial once the cell section
becomes thinner (Fig. 2 C). It is important to recognize
that the method breaks down once the cell thickness falls
below a critical value, because the optical resolution of
the z-scan is insufficient to pick out the broadening of the
green-channel profile. We discarded all measurements
with a thickness of <0.5 mm, which is the critical thickness
for the setup discussed in this article.
The intensity contrast between the z-scan at a puncta-
positive (Fig. 2 D) and experimental z-scans at puncta-
negative (Fig. 2, B and C) positions clearly demonstrate
the existence of a nonpunctate population of Gag at the
membrane. The nonpunctate Gag population has to have a
low degree of oligomerization, otherwise z-scan FFS mea-
surements at thin cytoplasmic sections (Fig. 2 C) would
yield large brightness values, which was not observed. In
addition, kymographs confirm that the Gag membrane frac-
tion persists for many minutes, whereas its fluorescence
intensity fluctuates with time (see Fig. S2 B of the Support-
ing Material). This implies that the nonpunctate membrane
fraction is mobile and spatially distributed.
The nonpunctate fraction is not uniformly distributed
across the plasma membrane, because we have found both
membrane-negative and membrane-positive locations
within a single cell. To the best of our knowledge, our results
provide the first direct observation of a nonpunctate Gag
population at the plasma membrane of living cells. How-
ever, our finding is not unexpected, as it is well known
that low-order HIV-1 Gag complexes are capable of binding
the plasma membrane (for reviews, see Swanstrom and
Wills (9) and Klein et al. (10)). In addition, biochemical
experiments indicate the interaction of HTLV-1 Gag with
the plasma membranes of 293T cells (31).
Because the focus of this article is the characterization
of cytoplasmic Gag-Gag interactions, we eliminatedBiophysical Journal 100(6) 1587–1595
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FFS and directly recorded cytoplasmic Gag-EYFP bright-
ness values that appear free of artifacts. Brightness
analysis of wild-type HIV-1 Gag is consistent with the
myristoyl-switch model. The protein is monomeric at low
concentrations. The increase in brightness toward higher
concentration (Fig. 4 A) indicates the onset of Gag-Gag
interactions. Gag-Gag interactions initiate the myristoyl
switch, which targets wild-type oligomers to the membrane,
limiting Gag accumulation in the cytoplasm. By compar-
ison, the HIV-1 G2A Gag mutant is membrane-binding-
deficient as confirmed by the absence of membrane-positive
z-scans. This allows for the accumulation and consequent
oligomerization of G2AGag in the cytoplasm. Both proteins
indicate the onset of detectable Gag-Gag interactions at
~500 nM, but only the mutant establishes the formation of
dimer and higher-order Gag oligomers in the cytoplasm,
as membrane-targeting depletes the wild-type oligomers
(Fig. 4 B).
HTLV-1 and HIV-1 Gag show distinct differences in their
oligomerization. This difference is most clearly visible
when comparing their G2A mutants. The HTLV-1 G2A
Gag lacked the concentration-dependent oligomerization
behavior exhibited by HIV-1 G2A Gag, although both pro-
teins reach comparable concentrations in the cytoplasm
(Fig. 4, B and D). Although there is a slight trend upwards
in the HTLV-1 G2A brightness data with concentration,
the brightness data essentially indicate the absence of Gag
oligomerization in the concentration range accessible to
wild-type HTLV-1 Gag. Thus, according to the myristoyl
switch model, HTLV-1 Gag should not interact with the
membrane, which is clearly inconsistent with our experi-
mental z-scan data. Based on the above results we would
expect to observe monomeric HTLV-1 Gag in the cyto-
plasm. The experiment, however, detects a concentration-
independent normalized brightness with an unusual large
scatter with values ranging from 1 to 1.6 (Fig. 4, C and D).
The amplitude of the scatter is much larger than expected
from the experimental uncertainty of brightness measure-
ments (see the Supporting Material). Although the reason
for this scatter is unknown, its presence indicates that
parameters other than concentration play a role in deter-
mining HTLV-1 Gag oligomerization.
Our data suggest that the myristoyl moiety might play a
different role in Gag oligomerization for HTLV-1 when
compared to HIV-1 Gag. Our observations are consistent
with a model where HTLV-1 Gag is capable of targeting
the membrane without the requirement of prior cytoplasmic
interactions. This result implies myristoyl moiety exposure
on HTLV-1 Gag monomers, which lies in contrast to the
sequestered myristoyl moiety of HIV-1 Gag monomers.
The evidence is consistent with previous biochemical
work by Rayne et al. (31,32), which found no evidence
for HTLV-1 G2A mutant interactions in cell extracts. This
difference in membrane targeting that HTLV-1 Gag exhibitsBiophysical Journal 100(6) 1587–1595may be a contributing factor to the concentration-indepen-
dent brightness scatter observed for the wild-type species.
More work needs to be done to account for the impact of
such a model in our interpretation of observed cytoplasmic
brightnesses for HTLV-1 Gag.
Performing FFS measurements on cytoplasmic proteins
with a membrane-bound population requires special precau-
tions to avoid artifacts. Although it is straightforward to
identify and avoid bright puncta, the presence of a dispersed
membrane-bound population is much more difficult to
recognize. The introduction of dual-color z-scan FFS
provides a convenient method to identify the presence of
membrane-bound protein. Furthermore, we removed bright-
ness artifacts by selecting membrane-negative z-scan
FFS data and performed the first quantification of Gag olig-
omerization in the cytoplasm of living cells. Our data
demonstrate that cytoplasmic HIV-1 and HTLV-1 Gag differ
in their interactions, which suggests differences in the
assembly pathway of both viruses. Further work is needed
to investigate these differences.
Cytoplasmic proteins that interact with the membrane are
ubiquitous. We expect that dual-color z-scan FFS will prove
useful in the brightness characterization of such proteins. At
this point, dual color z-scan FFS is used to reject membrane-
positive data. A potentially interesting and useful extension
of the technique would allow the simultaneous characteriza-
tion of cytoplasmic and membrane-bound proteins. In the
future, we hope to apply such a technique toward a better
understanding of retroviral assembly.SUPPORTING MATERIAL
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